Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA calls for updated product safety data:

This article was originally published in Clinica

Executive Summary

The FDA has asked for updated safety data on certain products to help it reach decisions on reclassification. The request applies to Class III devices in 15 product areas which were on the market prior to 1976. The agency intends to review whether these should be reclassified as Class II or I devices or be subject to a PMA review. The FDA said manufacturers need to submit their 515(i) information by August 14th and recommended that companies making similar products collaborate on a single document for submission.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT084374

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel